Whereas calcineurin inhibitors are usually the first choice for immunosuppression, cases of tacrolimus-induced reversible heart failure have been rarely described. To add to the existing limited literature and to help clinicians, we report 2 cases of patients who developed a dilated hypokinetic cardiomyopathy early after initiating this form of immunosuppression.
Reversible Tacrolimus-Induced Dilated Hypokinetic Cardiomyopathy / Di Pietro, G., Mennini, G., Ciuffreda, A., Birtolo, L.I., Cimino, S., Celli, P., Ascione, A., Iannello, L., Galea, N., Maestrini, V.. - In: JACC. CASE REPORTS. - ISSN 2666-0849. - 30:21(2025). [10.1016/j.jaccas.2025.104336]
Reversible Tacrolimus-Induced Dilated Hypokinetic Cardiomyopathy
Di Pietro G.;Mennini G.;Ciuffreda A.;Birtolo L. I.;Cimino S.;Celli P.;Ascione A.;Iannello L.;Galea N.;Maestrini V.
2025
Abstract
Whereas calcineurin inhibitors are usually the first choice for immunosuppression, cases of tacrolimus-induced reversible heart failure have been rarely described. To add to the existing limited literature and to help clinicians, we report 2 cases of patients who developed a dilated hypokinetic cardiomyopathy early after initiating this form of immunosuppression.| File | Dimensione | Formato | |
|---|---|---|---|
|
di-pietro-et-al-2025-reversible-tacrolimus-induced-dilated-hypokinetic-cardiomyopathy.pdf
accesso aperto
Note: Di Pietro_Reversible_2025
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
881.95 kB
Formato
Adobe PDF
|
881.95 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
